img

Global Histone Deacetylase (HDAC) Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Histone Deacetylase (HDAC) Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Histone Deacetylase (HDAC) Inhibitors report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Histone Deacetylase (HDAC) Inhibitors market is projected to reach US$ 1223.2 million in 2029, increasing from US$ 615.2 million in 2022, with the CAGR of 8.8% during the period of 2024 to 2029. Demand from Treatment of Malignant Tumors and Chronic Disease Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Histone Deacetylase (HDAC) Inhibitors industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Histone Deacetylase (HDAC) Inhibitors key manufacturers include 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma and Mirati Therapeutics, etc. 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics are top 3 players and held % sales share in total in 2022.
Histone Deacetylase (HDAC) Inhibitors can be divided into Fatty Acid, Hydroxamate, Cyclic Peptide and Benzamide, etc. Fatty Acid is the mainstream product in the market, accounting for % sales share globally in 2022.
Histone Deacetylase (HDAC) Inhibitors is widely used in various fields, such as Treatment of Malignant Tumors, Chronic Disease Treatment and Others,, etc. Treatment of Malignant Tumors provides greatest supports to the Histone Deacetylase (HDAC) Inhibitors industry development. In 2022, global % sales of Histone Deacetylase (HDAC) Inhibitors went into Treatment of Malignant Tumors filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Histone Deacetylase (HDAC) Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


4SC
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic
Segment by Type
Fatty Acid
Hydroxamate
Cyclic Peptide
Benzamide

Segment by Application


Treatment of Malignant Tumors
Chronic Disease Treatment
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Histone Deacetylase (HDAC) Inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Histone Deacetylase (HDAC) Inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Histone Deacetylase (HDAC) Inhibitors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Histone Deacetylase (HDAC) Inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Histone Deacetylase (HDAC) Inhibitors introduction, etc. Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Histone Deacetylase (HDAC) Inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Histone Deacetylase (HDAC) Inhibitors Market Overview
1.1 Histone Deacetylase (HDAC) Inhibitors Product Overview
1.2 Histone Deacetylase (HDAC) Inhibitors Market Segment by Type
1.2.1 Fatty Acid
1.2.2 Hydroxamate
1.2.3 Cyclic Peptide
1.2.4 Benzamide
1.3 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Type
1.3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global Histone Deacetylase (HDAC) Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2024)
2 Global Histone Deacetylase (HDAC) Inhibitors Market Competition by Company
2.1 Global Top Players by Histone Deacetylase (HDAC) Inhibitors Sales (2018-2024)
2.2 Global Top Players by Histone Deacetylase (HDAC) Inhibitors Revenue (2018-2024)
2.3 Global Top Players by Histone Deacetylase (HDAC) Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers Histone Deacetylase (HDAC) Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation and Trends
2.5.1 Histone Deacetylase (HDAC) Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Histone Deacetylase (HDAC) Inhibitors Market
2.8 Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Histone Deacetylase (HDAC) Inhibitors Status and Outlook by Region
3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Region
3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global Histone Deacetylase (HDAC) Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Region
3.3.1 Global Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global Histone Deacetylase (HDAC) Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global Histone Deacetylase (HDAC) Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Histone Deacetylase (HDAC) Inhibitors by Application
4.1 Histone Deacetylase (HDAC) Inhibitors Market Segment by Application
4.1.1 Treatment of Malignant Tumors
4.1.2 Chronic Disease Treatment
4.1.3 Others
4.2 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Application
4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2024)
5 North America Histone Deacetylase (HDAC) Inhibitors by Country
5.1 North America Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Country
5.1.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2018-2024)
5.2 North America Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Country
5.2.1 North America Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2024-2029)
6 Europe Histone Deacetylase (HDAC) Inhibitors by Country
6.1 Europe Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Country
6.1.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Country
6.2.1 Europe Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors by Region
7.1 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales in Value by Region (2024-2029)
8 Latin America Histone Deacetylase (HDAC) Inhibitors by Country
8.1 Latin America Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Country
8.1.1 Latin America Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors by Country
9.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 4SC
10.1.1 4SC Company Information
10.1.2 4SC Introduction and Business Overview
10.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Products Offered
10.1.5 4SC Recent Development
10.2 Acetylon Pharmaceuticals
10.2.1 Acetylon Pharmaceuticals Company Information
10.2.2 Acetylon Pharmaceuticals Introduction and Business Overview
10.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Products Offered
10.2.5 Acetylon Pharmaceuticals Recent Development
10.3 Celleron Therapeutics
10.3.1 Celleron Therapeutics Company Information
10.3.2 Celleron Therapeutics Introduction and Business Overview
10.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
10.3.5 Celleron Therapeutics Recent Development
10.4 Chipscreen Biosciences
10.4.1 Chipscreen Biosciences Company Information
10.4.2 Chipscreen Biosciences Introduction and Business Overview
10.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Products Offered
10.4.5 Chipscreen Biosciences Recent Development
10.5 Chroma Therapeutics
10.5.1 Chroma Therapeutics Company Information
10.5.2 Chroma Therapeutics Introduction and Business Overview
10.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
10.5.5 Chroma Therapeutics Recent Development
10.6 CrystalGenomics
10.6.1 CrystalGenomics Company Information
10.6.2 CrystalGenomics Introduction and Business Overview
10.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Products Offered
10.6.5 CrystalGenomics Recent Development
10.7 Curis
10.7.1 Curis Company Information
10.7.2 Curis Introduction and Business Overview
10.7.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Curis Histone Deacetylase (HDAC) Inhibitors Products Offered
10.7.5 Curis Recent Development
10.8 MEI Pharma
10.8.1 MEI Pharma Company Information
10.8.2 MEI Pharma Introduction and Business Overview
10.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Products Offered
10.8.5 MEI Pharma Recent Development
10.9 Mirati Therapeutics
10.9.1 Mirati Therapeutics Company Information
10.9.2 Mirati Therapeutics Introduction and Business Overview
10.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
10.9.5 Mirati Therapeutics Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Products Offered
10.10.5 Novartis Recent Development
10.11 Onxeo
10.11.1 Onxeo Company Information
10.11.2 Onxeo Introduction and Business Overview
10.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Products Offered
10.11.5 Onxeo Recent Development
10.12 Repligen
10.12.1 Repligen Company Information
10.12.2 Repligen Introduction and Business Overview
10.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Repligen Histone Deacetylase (HDAC) Inhibitors Products Offered
10.12.5 Repligen Recent Development
10.13 TetraLogic
10.13.1 TetraLogic Company Information
10.13.2 TetraLogic Introduction and Business Overview
10.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.13.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Products Offered
10.13.5 TetraLogic Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Histone Deacetylase (HDAC) Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Histone Deacetylase (HDAC) Inhibitors Industrial Chain Analysis
11.4 Histone Deacetylase (HDAC) Inhibitors Market Dynamics
11.4.1 Histone Deacetylase (HDAC) Inhibitors Industry Trends
11.4.2 Histone Deacetylase (HDAC) Inhibitors Market Drivers
11.4.3 Histone Deacetylase (HDAC) Inhibitors Market Challenges
11.4.4 Histone Deacetylase (HDAC) Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Histone Deacetylase (HDAC) Inhibitors Distributors
12.3 Histone Deacetylase (HDAC) Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Fatty Acid
Table 2. Major Company of Hydroxamate
Table 3. Major Company of Cyclic Peptide
Table 4. Major Company of Benzamide
Table 5. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024) & (MT)
Table 7. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 9. Global Histone Deacetylase (HDAC) Inhibitors Market Share in Value by Type (2018-2024)
Table 10. Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2018-2024) & (USD/MT)
Table 11. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2024-2029) & (MT)
Table 12. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Type (2024-2029)
Table 15. Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2024-2029) & (USD/MT)
Table 16. North America Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024) & (MT)
Table 17. North America Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2018-2024)
Table 19. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2018-2024)
Table 21. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2018-2024)
Table 23. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2018-2024)
Table 25. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Histone Deacetylase (HDAC) Inhibitors Sales by Company (2018-2024) & (MT)
Table 27. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Company (2018-2024)
Table 28. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Company (2018-2024)
Table 30. Global Market Histone Deacetylase (HDAC) Inhibitors Price by Company (2018-2024) & (USD/MT)
Table 31. Global Histone Deacetylase (HDAC) Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Histone Deacetylase (HDAC) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2022)
Table 34. Date of Key Manufacturers Enter into Histone Deacetylase (HDAC) Inhibitors Market
Table 35. Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Histone Deacetylase (HDAC) Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2018-2024) & (MT)
Table 39. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 42. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2024-2029) & (MT)
Table 44. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 47. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 48. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) & (MT)
Table 50. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 53. Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2018-2024) & (USD/MT)
Table 54. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2024-2029) & (MT)
Table 55. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Application (2024-2029)
Table 58. Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2024-2029) & (USD/MT)
Table 59. North America Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) (MT)
Table 60. North America Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) (MT)
Table 62. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) (MT)
Table 64. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) (MT)
Table 66. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) (MT)
Table 68. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (MT)
Table 70. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 73. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (MT)
Table 74. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (MT)
Table 78. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (MT)
Table 82. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2018-2024) & (MT)
Table 86. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2024-2029) & (MT)
Table 90. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (MT)
Table 94. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (MT)
Table 98. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (MT)
Table 102. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (MT)
Table 106. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 109. 4SC Company Information
Table 110. 4SC Introduction and Business Overview
Table 111. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. 4SC Histone Deacetylase (HDAC) Inhibitors Product
Table 113. 4SC Recent Development
Table 114. Acetylon Pharmaceuticals Company Information
Table 115. Acetylon Pharmaceuticals Introduction and Business Overview
Table 116. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product
Table 118. Acetylon Pharmaceuticals Recent Development
Table 119. Celleron Therapeutics Company Information
Table 120. Celleron Therapeutics Introduction and Business Overview
Table 121. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 123. Celleron Therapeutics Recent Development
Table 124. Chipscreen Biosciences Company Information
Table 125. Chipscreen Biosciences Introduction and Business Overview
Table 126. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product
Table 128. Chipscreen Biosciences Recent Development
Table 129. Chroma Therapeutics Company Information
Table 130. Chroma Therapeutics Introduction and Business Overview
Table 131. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 133. Chroma Therapeutics Recent Development
Table 134. CrystalGenomics Company Information
Table 135. CrystalGenomics Introduction and Business Overview
Table 136. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product
Table 138. CrystalGenomics Recent Development
Table 139. Curis Company Information
Table 140. Curis Introduction and Business Overview
Table 141. Curis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 142. Curis Histone Deacetylase (HDAC) Inhibitors Product
Table 143. Curis Recent Development
Table 144. MEI Pharma Company Information
Table 145. MEI Pharma Introduction and Business Overview
Table 146. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 147. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product
Table 148. MEI Pharma Recent Development
Table 149. Mirati Therapeutics Company Information
Table 150. Mirati Therapeutics Introduction and Business Overview
Table 151. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 152. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 153. Mirati Therapeutics Recent Development
Table 154. Novartis Company Information
Table 155. Novartis Introduction and Business Overview
Table 156. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 157. Novartis Histone Deacetylase (HDAC) Inhibitors Product
Table 158. Novartis Recent Development
Table 159. Onxeo Company Information
Table 160. Onxeo Introduction and Business Overview
Table 161. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 162. Onxeo Histone Deacetylase (HDAC) Inhibitors Product
Table 163. Onxeo Recent Development
Table 164. Repligen Company Information
Table 165. Repligen Introduction and Business Overview
Table 166. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 167. Repligen Histone Deacetylase (HDAC) Inhibitors Product
Table 168. Repligen Recent Development
Table 169. TetraLogic Company Information
Table 170. TetraLogic Introduction and Business Overview
Table 171. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 172. TetraLogic Histone Deacetylase (HDAC) Inhibitors Product
Table 173. TetraLogic Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Histone Deacetylase (HDAC) Inhibitors Market Trends
Table 177. Histone Deacetylase (HDAC) Inhibitors Market Drivers
Table 178. Histone Deacetylase (HDAC) Inhibitors Market Challenges
Table 179. Histone Deacetylase (HDAC) Inhibitors Market Restraints
Table 180. Histone Deacetylase (HDAC) Inhibitors Distributors List
Table 181. Histone Deacetylase (HDAC) Inhibitors Downstream Customers
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Histone Deacetylase (HDAC) Inhibitors Product Picture
Figure 2. Global Histone Deacetylase (HDAC) Inhibitors Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Histone Deacetylase (HDAC) Inhibitors Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Histone Deacetylase (HDAC) Inhibitors Sales Status and Outlook (2018-2029) & (MT)
Figure 5. Product Picture of Fatty Acid
Figure 6. Global Fatty Acid Sales YoY Growth (2018-2029) & (MT)
Figure 7. Product Picture of Hydroxamate
Figure 8. Global Hydroxamate Sales YoY Growth (2018-2029) & (MT)
Figure 9. Product Picture of Cyclic Peptide
Figure 10. Global Cyclic Peptide Sales YoY Growth (2018-2029) & (MT)
Figure 11. Product Picture of Benzamide
Figure 12. Global Benzamide Sales YoY Growth (2018-2029) & (MT)
Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type in 2022 & 2029
Figure 15. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 16. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Type in 2022
Figure 17. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Histone Deacetylase (HDAC) Inhibitors Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Histone Deacetylase (HDAC) Inhibitors Revenue in 2022
Figure 27. Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Treatment of Malignant Tumors
Figure 29. Global Treatment of Malignant Tumors Sales YoY Growth (2018-2029) & (MT)
Figure 30. Product Picture of Chronic Disease Treatment
Figure 31. Global Chronic Disease Treatment Sales YoY Growth (2018-2029) & (MT)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (MT)
Figure 34. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application in 2022 & 2029
Figure 36. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 37. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Application in 2022
Figure 38. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 39. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Application in 2022
Figure 42. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Histone Deacetylase (HDAC) Inhibitors Manufacturing Cost Structure
Figure 47. Histone Deacetylase (HDAC) Inhibitors Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries